PMID- 11919402 OWN - NLM STAT- MEDLINE DCOM- 20020606 LR - 20171101 IS - 0250-8095 (Print) IS - 0250-8095 (Linking) VI - 22 IP - 1 DP - 2002 Jan-Feb TI - Correlation between soluble markers of endothelial dysfunction in patients with renal failure. PG - 42-7 AB - AIM: Damage to the endothelium is an important component of atherosclerosis. It has been suggested to be quantified by measuring plasma markers, such as von Willebrand factor and thrombomodulin and soluble adhesion molecules. We hypothesized there may exist a correlation between the plasma levels of von Willebrand factor and thrombomodulin as markers of endothelial cell dysfunction and the serum concentrations of soluble adhesion molecules and monocyte chemoattractant protein-1 (MCP-1) in patients with renal insufficiency, and in patients on peritoneal dialysis or hemodialysis since these three groups of kidney patients are highly prone to develop cardiovascular diseases. RESULTS: The concentrations of von Willebrand factor and thrombomodulin in plasma were significantly higher in patients with kidney diseases as compared to healthy subjects (p = 0.017 and p < 0.001, respectively). The patients also had significantly higher concentrations of soluble vascular cell adhesion molecule-1 (sVCAM-1) and MCP-1 compared to healthy controls (p < 0.001 for both comparisons). There were strong correlations between the concentration of soluble intercellular adhesion molecule-1 (sICAM-1) and von Willebrand factor in patients with kidney failure (r = 0.63, p < 0.001) and between the concentration of thrombomodulin and sVCAM-1 (r = 0.61, p < 0.001). Furthermore, a negative correlation was observed between the concentration of thrombomodulin and the cell surface expression of CD11b on monocytes and granulocytes in the peripheral circulation (p < 0.01 in both cases). CONCLUSION: The strong correlation between markers of endothelial dysfunction and soluble adhesion molecules in patients with renal insufficiency and on dialysis strengthen the view that an ongoing stress on endothelial cells is present in this group of patients. This may play a pathophysiological role in the development of cardiovascular disease. CI - Copyright 2002 S. Karger AG, Basel FAU - Jacobson, Stefan H AU - Jacobson SH AD - Department of Medicine, Division of Nephrology, Karolinska Hospital and Karolinska Institute, Stockholm, Sweden. stefan.jacobson@ks.se FAU - Egberg, Nils AU - Egberg N FAU - Hylander, Britta AU - Hylander B FAU - Lundahl, Joachim AU - Lundahl J LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Switzerland TA - Am J Nephrol JT - American journal of nephrology JID - 8109361 RN - 0 (Thrombomodulin) RN - 0 (Vascular Cell Adhesion Molecule-1) RN - 0 (von Willebrand Factor) RN - 126547-89-5 (Intercellular Adhesion Molecule-1) SB - IM MH - Aged MH - Arteriosclerosis/*blood MH - Endothelium, Vascular/*pathology/physiopathology MH - Humans MH - Inflammation MH - Intercellular Adhesion Molecule-1/blood MH - Kidney Failure, Chronic/*blood MH - Male MH - Middle Aged MH - Renal Dialysis MH - Thrombomodulin/*blood MH - Vascular Cell Adhesion Molecule-1/blood MH - von Willebrand Factor/*analysis EDAT- 2002/03/29 10:00 MHDA- 2002/06/12 10:01 CRDT- 2002/03/29 10:00 PHST- 2002/03/29 10:00 [pubmed] PHST- 2002/06/12 10:01 [medline] PHST- 2002/03/29 10:00 [entrez] AID - 46673 [pii] AID - 10.1159/000046673 [doi] PST - ppublish SO - Am J Nephrol. 2002 Jan-Feb;22(1):42-7. doi: 10.1159/000046673.